Huons
Korea - SeongnamBiotechnology
Focus: Huons is a Korean biotechnology company focused on small-molecule therapeutics across ophthalmology, metabolic diseases, cardiovascular, and neurology indications. The company operates from Seongnam, Korea with a diversified pipeline spanning early to late-stage development.
Profile data last refreshed 16h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Huons
AI assessmentNot HiringNo open roles listed right now. Follow Huons to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Huons's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
12 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Post-LOE
ANDA generic in post-LOE phase with diminishing revenue contribution.
Help build intelligence for Huons
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.